Literature DB >> 21109497

Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity.

Franck Mauvais-Jarvis1.   

Abstract

Because of increasing life expectancy, the contribution of age-related estrogen or androgen deficiency to obesity and type 2 diabetes will become a new therapeutic challenge. This review integrates current concepts on the mechanisms through which estrogen receptors (ERs) and androgen receptor (AR) regulate energy homeostasis in rodents and humans. In females, estrogen maintains energy homeostasis via ERα and ERβ, by suppressing energy intake and lipogenesis, enhancing energy expenditure, and ameliorating insulin secretion and sensitivity. In males, testosterone is converted to estrogen and maintains fuel homeostasis via ERs and AR, which share related functions to suppress adipose tissue accumulation and improve insulin sensitivity. We suggest that ERs and AR could be potential targets in the prevention of age-related metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109497      PMCID: PMC3011051          DOI: 10.1016/j.tem.2010.10.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  94 in total

1.  Lower endogenous androgens predict central adiposity in men.

Authors:  K T Khaw; E Barrett-Connor
Journal:  Ann Epidemiol       Date:  1992-09       Impact factor: 3.797

Review 2.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

3.  Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Authors:  C B Verchere; D A D'Alessio; R D Palmiter; G C Weir; S Bonner-Weir; D G Baskin; S E Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Effects of testosterone on muscle insulin sensitivity and morphology in female rats.

Authors:  A Holmäng; J Svedberg; E Jennische; P Björntorp
Journal:  Am J Physiol       Date:  1990-10

5.  Defects in beta-cell function in functional ovarian hyperandrogenism.

Authors:  N M O'Meara; J D Blackman; D A Ehrmann; R B Barnes; J B Jaspan; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

6.  Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.

Authors:  J Holte; T Bergh; C Berne; L Berglund; H Lithell
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

7.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

Authors:  E P Smith; J Boyd; G R Frank; H Takahashi; R M Cohen; B Specker; T C Williams; D B Lubahn; K S Korach
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

8.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.

Authors:  Y Lee; H Hirose; M Ohneda; J H Johnson; J D McGarry; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

9.  Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.

Authors:  Y Tokuyama; J Sturis; A M DePaoli; J Takeda; M Stoffel; J Tang; X Sun; K S Polonsky; G I Bell
Journal:  Diabetes       Date:  1995-12       Impact factor: 9.461

10.  Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.

Authors:  A Morishima; M M Grumbach; E R Simpson; C Fisher; K Qin
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

View more
  106 in total

1.  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

Authors:  Andrea Clocchiatti; Soumitra Ghosh; Maria-Giuseppina Procopio; Luigi Mazzeo; Pino Bordignon; Paola Ostano; Sandro Goruppi; Giulia Bottoni; Atul Katarkar; Mitchell Levesque; Peter Kölblinger; Reinhard Dummer; Victor Neel; Berna C Özdemir; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

2.  Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

Review 3.  [Surgery as pluripotent instrument for metabolic disease. What are the mechanisms?].

Authors:  C Corteville; M Fassnacht; M Bueter
Journal:  Chirurg       Date:  2014-11       Impact factor: 0.955

Review 4.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

5.  Targeted estrogen delivery reverses the metabolic syndrome.

Authors:  Brian Finan; Bin Yang; Nickki Ottaway; Kerstin Stemmer; Timo D Müller; Chun-Xia Yi; Kirk Habegger; Sonja C Schriever; Cristina García-Cáceres; Dhiraj G Kabra; Jazzminn Hembree; Jenna Holland; Christine Raver; Randy J Seeley; Wolfgang Hans; Martin Irmler; Johannes Beckers; Martin Hrabě de Angelis; Joseph P Tiano; Franck Mauvais-Jarvis; Diego Perez-Tilve; Paul Pfluger; Lianshan Zhang; Vasily Gelfanov; Richard D DiMarchi; Matthias H Tschöp
Journal:  Nat Med       Date:  2012-11-11       Impact factor: 53.440

6.  Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells.

Authors:  Geetanjali Sharma; Eric R Prossnitz
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

7.  Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.

Authors:  Jun Ho Kim; Matthew S Meyers; Saja S Khuder; Simon L Abdallah; Harrison T Muturi; Lucia Russo; Chandra R Tate; Andrea L Hevener; Sonia M Najjar; Corinne Leloup; Franck Mauvais-Jarvis
Journal:  Mol Metab       Date:  2014-01-09       Impact factor: 7.422

8.  Ventromedial hypothalamic glucose sensing and glucose homeostasis vary throughout the estrous cycle.

Authors:  Ammy M Santiago; Deborah J Clegg; Vanessa H Routh
Journal:  Physiol Behav       Date:  2016-09-22

9.  Effect of ovariectomy on serum adiponectin levels and visceral fat in rats.

Authors:  Ce Camara; Lin-Yuan Zhou; Yan Ma; Lin Zhu; Dong Yu; Yao-Wu Zhao; Nian-Hong Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

10.  Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.

Authors:  Hui Yan; Wangbao Yang; Fenghua Zhou; Xiaopeng Li; Quan Pan; Zheng Shen; Guichun Han; Annie Newell-Fugate; Yanan Tian; Ravikumar Majeti; Wenshe Liu; Yong Xu; Chaodong Wu; Kimberly Allred; Clinton Allred; Yuxiang Sun; Shaodong Guo
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.